SAM
AGN

Shamrock Asset Management’s Allergan Inc AGN Stock Holding History

Shamrock Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-100
Closed -$27K – 288
2015
Q3 		$27K Buy
+100
New +$27K 0.01% 171

Other funds holding AGN

SL
Summitry LLC Foster City, California $2.83B AUM 17.32% 1-Year Est. Return
AWM
Altavista Wealth Management Asheville, North Carolina $496M AUM 20.88% 1-Year Est. Return
III
Independent Investors Inc Nesconset, New York $524M AUM 29.67% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
MMPW
Mitchell McLeod Pugh & Williams Mobile, Alabama $678M AUM 23.02% 1-Year Est. Return
ODCM
Old Dominion Capital Management Charlottesville, Virginia $467M AUM 25.94% 1-Year Est. Return
DY
Dowling & Yahnke San Diego, California $2.15B AUM 10.82% 1-Year Est. Return
HHAA
Henry H. Armstrong Associates Pittsburgh, Pennsylvania $1.03B AUM 4.23% 1-Year Est. Return
AGA
Accuvest Global Advisors Provo, Utah $107M AUM 6.41% 1-Year Est. Return
LCM
Liberty Capital Management Birmingham, Michigan $582M AUM

Shamrock Asset Management's AGN Position: Q4 2015 in Review

Shamrock Asset Management sold out of Allergan Inc (AGN) in Q4 2015, closing a stake of 100 shares — an estimated $27K sold.

Shamrock Asset Management first reported a position in AGN in Q3 2015 and held it in 1 quarter. The position peaked at $27K in Q3 2015. 28 funds tracked by Wall St. Rank hold AGN as of Q4 2015.

  • Shamrock Asset Management reported no remaining Allergan Inc position as of Q4 2015 after selling out during the quarter.
  • Shamrock Asset Management sold 100 Allergan Inc shares in Q4 2015, an estimated $27K.
  • Shamrock Asset Management first reported a position in Allergan Inc in Q3 2015 and held it in 1 quarter.
  • Shamrock Asset Management's Allergan Inc position peaked at $27K in Q3 2015.
  • 28 funds tracked by Wall St. Rank held Allergan Inc as of Q4 2015.

Based on Shamrock Asset Management's 13F filing for Q4 2015, filed 1 Feb 2016.